文献速递青光眼

生物学年龄加速、遗传易感性与青光眼发病风险

Biological Age Acceleration, Genetic Susceptibility, and Incident Glaucoma Risk.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2025-01-01

在318,556名无基线青光眼的英国生物银行参与者中,中位随访13.5年间6553人发生青光眼。KDM-BA与PhenoAge生物学年龄加速均与青光眼风险升高相关,遗传风险修饰该关联,但孟德尔随机化未发现因果关系。

要点

  • 生物学年龄每加速5年,KDM-BA法青光眼风险HR 1.12(95%CI 1.07-1.16),PhenoAge法HR 1.09(95%CI 1.06-1.13)。
  • 生物学年龄较老者青光眼风险更高,KDM-BA法HR 1.10(95%CI 1.05-1.16),PhenoAge法HR 1.07(95%CI 1.02-1.13)。
  • 生物学年龄较老且遗传风险高者青光眼风险最高,KDM-BA法HR 2.33(95%CI 2.15-2.52),PhenoAge法HR 2.21(95%CI 2.05-2.38)。

核心结论

  • 生物学年龄加速与青光眼发病风险升高相关,且该关联受遗传风险修饰。
  • 孟德尔随机化分析未发现因果关系,原文指出需进一步研究以探究该关联的本质。

研究设计与样本

  • 研究纳入318,556名英国生物银行无基线青光眼的参与者。
  • 采用Klemera-Doubal法生物学年龄(KDM-BA)与PhenoAge算法计算生物学年龄。
  • 使用Cox回归模型分析生物学年龄加速与青光眼发病的关联及其与遗传风险的交互作用,并用孟德尔随机化分析探究因果关联。

主要发现

  • 中位随访13.5年间,6553名参与者发生青光眼。
  • 生物学年龄每加速5年与青光眼风险升高相关:KDM-BA加速HR 1.12(95%CI 1.07-1.16),PhenoAge加速HR 1.09(95%CI 1.06-1.13)。
  • 生物学年龄较老者较年轻者青光眼风险更高:KDM-BA加速HR 1.10(95%CI 1.05-1.16),PhenoAge加速HR 1.07(95%CI 1.02-1.13)。
  • 遗传风险修饰上述关联(交互作用P值均<0.05)。
  • 生物学年龄较老且遗传风险高者青光眼风险最高:KDM-BA加速HR 2.33(95%CI 2.15-2.52),PhenoAge加速HR 2.21(95%CI 2.05-2.38)。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 孟德尔随机化分析未发现因果关系。
  • 原文指出需进一步研究以探究该关联的本质。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To evaluate the association of biological age acceleration with incident glaucoma risk and examine whether genetic predisposition modifies it. METHODS: We included 318,556 UK Biobank participants without baseline glaucoma. Biological age was calculated using the Klemera-Doubal method Biological Age (KDM-BA) and PhenoAge algorithms. Hazard ratios (HRs) and 95% confidence intervals (CIs) of the association between biological age acceleration and incident glaucoma, and their interaction with genetic risk were analyzed by Cox regression models. Mendelian randomization analyses investigated causal associations. RESULTS: After a median follow-up of 13.5 years, 6553 participants developed glaucoma. Biological age acceleration was associated with an increased glaucoma risk. Each 5-year increment in biological age acceleration was linked to higher glaucoma risk (KDM-BA acceleration: HR, 1.12, 95% CI, 1.07-1.16; PhenoAge acceleration, HR, 1.09, 95% CI, 1.06-1.13). Biologically older participants had a higher glaucoma risk than younger participants (KDM-BA acceleration, HR, 1.10, 95% CI, 1.05-1.16; PhenoAge acceleration, HR, 1.07, 95% CI, 1.02-1.13). Genetic risk modified these relationships (all P for interactions < 0.05). Biologically older participants with high genetic risk had the highest glaucoma risk (KDM-BA acceleration, HR, 2.33, 95% CI, 2.15-2.52; PhenoAge acceleration, HR, 2.21, 95% CI, 2.05-2.38). No causal relationships were found in the Mendelian randomization analysis. CONCLUSIONS: Biological age acceleration was associated with an increased glaucoma risk, and this relationship was modified by genetic risk. However, no causal relationship was established, and further research is needed to investigate the nature of the association.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Song WQ, Zhong WF, Li ZH, et al. Biological Age Acceleration, Genetic Susceptibility, and Incident Glaucoma Risk. Invest Ophthalmol Vis Sci. 2025. PMID: 40244607. doi:10.1167/iovs.66.4.47

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。